Ignite Creation Date:
2024-05-05 @ 11:30 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00067002
Status:
COMPLETED
Last Update Posted:
2019-05-01
First Post:
2003-08-08
Brief Title:
Randomized Double Cord Blood Transplant Study
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Lymphoma Non-Hodgkin |
| Leukemia Lymphocytic Acute |
| Leukemia Myelocytic Acute |
| Leukemia Myeloid Chronic |
Keywords:
| Name | View |
|---|---|
| Mesnex | View |
| ALL | View |
| Leukemia Lymphocytic Acute | View |
| AML | View |
| Leukemia Myelocytic Acute | View |
| CML | View |
| Leukemia Myeloid Chronic | View |
| NHL | View |
| Lymphoma Non-Hodgkin | View |
| double cord blood transplant | View |
| expanded cord blood transplant | View |
| Rituxan | View |
| Rituximab | View |
| Melphalan | View |
| Alkeran | View |
| Thiotepa | View |
| Fludarabine | View |
| Fludarabine phosphate | View |
| Fludara | View |
| Cyclophosphamide | View |
| Cytoxan | View |
| Neosar | View |
| Mesna | View |